medigraphic.com
ISSN 0185-6014 (Impreso)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2008, Número 3

<< Anterior

Rev Mex Patol Clin Med Lab 2008; 55 (3)


Procalcitonina. Su papel como biomarcador de sepsis

Barba EJR

Idioma: Español
Referencias bibliográficas: 39
Paginas: 157-167
Archivo PDF: 149.02 Kb.


RESUMEN

Diversos autores han postulado que las mediciones de procalcitonina son superiores a las pruebas comúnmente utilizadas, como son las mediciones de proteína C reactiva, para el diagnóstico temprano de sepsis.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Hatherill M, Tibby SM, Sykes K, Turner C, Murdoch IA. Diagnostic markers of infection: Comparison of procalcitonina with C reactive protein and leucocyte count. Arch Dis Child 1999; 81: 417-421.

  2. Carrigan SD, Scott G, Tabrizian M. Toward resolving the challenges of sepsis diagnosis. Clinical Chemistry 2004; 50(8): 1301-1314.

  3. Sikora JP, Chlebna-Sokóe D, Krzyzanska-Oberbek A. Proinflammatory cytokines (IL-6, IL-8), cytokine inhibitors (IL-6sR, sTNFRII) and anti-inflammatory cytokines (IL-10, IL-13) in the pathogenesis of sepsis in newborns and infants. Archivum Immunologiae et Therapiae Experimentalis 2001; 49: 399-404.

  4. Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 2002: 26: S148-S152.

  5. Oberhoffer M, RuBwurm S, Bredle D, Chatzinicolaou K, Reinhart K. Discriminative power of inflammatory markers for prediction of tumor necrosis factor-a and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary time points. Intensive Care Med 2000; 26: S170-S174.

  6. Rau B, Steinbach G, Gansauge F, Mayer JM, Grünert A, Beger HG. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute Pancreatitis. Gut 1997; 41: 832-840.

  7. de Werra I, Jaccard C, Corradin SB, Chioléro R, Yersin B, Gallati H, Assicot M, Bohuon C, Jean-Daniel B, Glauser MP, Heumann D. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997; 25(4): 607-613.

  8. Fernández LA, Cubells CL, Tolosa CV, Ortega RJ, García GJJ, Vallet AM, Fernández JP. Procalcitonina para el diagnóstico precoz de infección bacteriana invasiva en el lactante febril. Anales Españoles de Pediatría 2001; 55(4): 321-328.

  9. Cheval C, Timsit JF, Garrouste-Orgeas M, Assicot M, De Jonghe B, Misset B, Bohuon C, Carlet J. Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients. Intensive Care Med 2002; 26: S153-S158.

  10. Meisner M, Schmidt J, Hüttner H, Tschaikowsky K. The natural elimination rate of procalcitonin in patients with normal and impaired renal function. Intensive Care Med 2000; 26: S212-S216.

  11. Nylén ES, Snider Jr RH, Thompson KA, Rohatgi P, Becker KL. Pneumonitis-associated hyperprocalcitoninemia. Am J Med Sci 1996; 312(1): 12-18.

  12. Müller B, White JC, Nylén ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001; 86: 396-404.

  13. Bohuon C. A brief history of procalcitonin. Intensive Care Med 2000; 26: S146-S147.

  14. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79: 1605-1608.

  15. Motte GP, Troalen FP et al. Identification and measurement of calcitonin precursors in serum of patients with malignant diseases. Cancer Res 1989; 49: 6845-6851.

  16. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-518.

  17. Janota J, Stranák Z, Bélohlávková S, Mudra K, Smák J. Postnatal increase of procalcitonin in premature newborns is enhanced by chorioamnionitis and neonatal sepsis. Europ J Clin Invest 2001; 31: 978-983.

  18. Marc E, Ménager C, Moulin F, Stos B, Chalumeau M, Guérin S, Lebon P, Brunet F, Raymond J, Gendrel D. Procalcitonin and viral meningitis: reducing unnecessary antibiotic treatments by routine analysis during an outbreak. Arch Pediatr 2002; 9: 358-364.

  19. Benador N, Claire-Anne S, Gendrel D, Greder C, Benador D, Assicot M, Bohuon C, Girardin E. Procalcitonin is a marker of severity of renal lesions in pyelonephritis. Pediatrics 1998; 102(6): 1422-1425.

  20. Kuse ER, Langefeld I, Aeger K, Külpmann WR. Procalcitonin-a new diagnostic tool in complications following liver transplantation. Intensive Care Med 2000; 26: S187-S192.

  21. Chiesa C, Panero A, Rossi N et al. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically neonates. Clin Infect Dis 1998; 26: 664-672.

  22. Monneret G, Labaune JM, Isaac C, Bienvenu F, Puter G, Bienvenu J. Procalcitonin and C-reactive protein levels in neonatal infections. Acta Paediatr 1997; 86: 209-212.

  23. Gendrel D, Bohuon C. Procalcitonin in pediatrics for differentiation of bacterial and viral infections. Intensive Care Med 2000; 26: S178-S181.

  24. Fleischhack G, Cipic D, Juettner J, Hasan C, Bode U. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer. Intensive Care Med 2000; 26: S202-S211.

  25. Gérard Y, Hober D, Petitjean S, Assicot M, Bohuon C, Mounton Y, Wattré P. High serum procalcitonin level in a 4-year-old liver transplant recipient with a disseminated candidiasis. Infection 1995; 23(5): 60/310-61/311.

  26. Rintala EM, Aittoniemi J, Laine S, Nevalainen TJ, Nikoskelainen J. Early identification of bacteremia by biochemical markers of systemic inflammation. Scand J Clin Lab Invest 2001; 61: 523-530.

  27. Smith MD, Suputtamongkol Y, Chaowagul W, Assicot M, Bohuon C, Petitjean S, White NJ. Elevated serum procalcitonin levels in patients with melioidosis. Clin Infec Dis 1995; 20: 641-645.

  28. Nylen ES, O´Neill W, Jordan MH, Zinder RH, Moore CF, Lewis M, Silva OL, Becker KL. Serum Procalcitonin as an index of inhalation injury in burns. Horm Metab Res 1992); 24: 439-442.

  29. Becker KL, O´Neil WJ, Snider RH Jr, Nylen ES, Moore CF, Jeng J, Silva OL, Lewis MS, Jordan MH. Hypercalcitonemia in inhalation burn injury: A response of the pulmonary neuroendocrine cell? The Anatomical Record 1993; 236: 136-138.

  30. O’Connor E, Venkatesh B, Mashongonyika C, Lipman J, Thomas P. Serum procalcitonin and C-reactive protein as markers of sepsis and outcome in patients with neurotrauma and subarachnoid haemorrhage. Anaesth Intensive Care 2004; 32: 465-470.

  31. Martínez R, Gaul C, Buchfelder M, Erbguth F, Tschaikosky K. Serum procalcitonin monitoring for differential diagnosis of ventriculitis in adult intensive care patients. Intensive Care Med 2002; 28: 208-210.

  32. Chiesa C, Pacifico L, Rossi N, Panero A, Matrunola M, Mancuso G. Procalcitonin as a marker of nosocomial infections in the neonatal intensive care unit. Intensive Care Med 2000; 26: S175-S177.

  33. Hammer S, Meisner F, Dirschendl P, Fraunberger P, Meiser B, Reichart B, Hammer C. Procalcitonin for differential diagnosis of graft rejection and infection in patients with heart and/or lung grafts. Intensive Care Med 2000; 26: S182-S186.

  34. Rau B, Steinbach G, Baumgart K, Gansauge F, Grünert A, Beger HG. The Clinical value of procalcitonin in the prediction of infected necrosis in acute pancreatitis. Intensive Care Med 2000; 26: S159-S164.

  35. Chiwakata CB, Manegold C, Bönicke L, Waase I, Jülch C, Dietrich M. Procalcitonin as a parameter of disease severity and risk of mortality in patients with Plasmodium falciparum malaria. J Infect Dis 2001; 183: 1161-1164.

  36. Loebe M, Locziewski S, Brunkhorst FM, Harke C, Hetzer R. Procalcitonin in patients undergoing cardiopulmonary bypass in open heart surgery-first results of the procalcitonin in heart surgery study (ProHearts). Intensive Care Med 2000; 26: S193-S198.

  37. Brunkhorst R, Eberhardt OK, Haubitz M, Brunkhorst FM. Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection. Intensive Care Med 2000; 26: S199-S201.

  38. Reith HB, Mittelkötter U, Wagner R, Thiede A. Procalcitonin (PCT) in patients with abdominal sepsis. Intensive Care Med 2000; 26: S165-S169.

  39. Reinhart K, Carlet J. Procalcitonin-a new marker of severe infection and sepsis. Intensive Care Med 2000: 26: S145




2020     |     www.medigraphic.com